The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes

被引：0
|
作者：
Andrew Lowey
Sara Moore
Catherine Norris
David Wright
Jonathan Silcock
Peter Hammond
机构：
[1] Harrogate & District Foundation Trust,Pharmacy Department
[2] Leeds Teaching Hospitals NHS Trust,Pharmacy Department, Gledhow Wing
[3] St. James University Hospital,School of Chemical Sciences and Pharmacy
[4] University of East Anglia,Pharmacy Practice and Medicines Management Group
[5] University of Leeds,undefined
来源：
Pharmacy World & Science | 2007年 / 29卷
关键词：
Diabetes mellitus; Hypertension; Hyperlipidaemia; Pharmacy; Cost-effectiveness; Cardiovascular risk; United Kingdom; Pharmacoeconomics; Pharmacist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：541 / 545
页数：4
相关论文
共 50 条
  • [31] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Te Li
    Xu Wan
    Jin Ma
    Bin Wu
    [J]. Advances in Therapy, 2018, 35 : 2214 - 2223
  • [32] The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes
    Mangesh Kharjul
    Rhiannon Braund
    James Green
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 354 - 359
  • [33] The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes
    Kharjul, Mangesh
    Braund, Rhiannon
    Green, James
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (02) : 354 - 359
  • [34] THE INFLUENCE OF PHARMACIST-LED ADHERENCE SUPPORT ON GLYCAEMIC CONTROL IN PEOPLE WITH TYPE 2 DIABETES
    Kharjul, Mangesh D.
    Green, James A.
    Braund, Rhiannon
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (08): : E46 - E46
  • [35] The cost-effectiveness of screening for type 2 diabetes
    Engelgau, MM
    Narayan, KMV
    Thompson, TJ
    Boyle, JP
    Williamson, DF
    Manninen, DL
    Dong, FB
    Orians, CE
    Dasbach, EJ
    Teutsch, SM
    Eastman, R
    Herman, WH
    Songer, TJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (20): : 1757 - 1763
  • [36] Pharmacist-led group medical visits for cardiovascular risk reduction in diabetes
    Taveira, Tracey H.
    Cohen, Lisa B.
    Pirraglia, Paul A.
    Friedmann, Peter D.
    Wu, Wen-Chih
    [J]. CIRCULATION, 2008, 117 (11)
  • [37] COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN PERU
    Elgart, J. F.
    Gonzalez, L.
    Prestes, M.
    Manrique, H.
    Solorzano, J.
    Gagliardino, J. J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A203 - A203
  • [38] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT HIGH CARDIOVASCULAR RISK IN POLAND
    Pawlik, D.
    Wojcik, R.
    Zawodnik, A.
    Kaczor, M. P.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A478 - A478
  • [39] MEDICATION COUNSELING BEYOND INSTITUTIONAL: IMPACT OF PHARMACIST-LED HOME MEDICATION REVIEW IN TYPE 2 DIABETES PATIENTS
    Chow, E. P.
    Hassali, A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A746 - A746
  • [40] A randomized controlled trial of a pharmacist-led intervention to enhance knowledge of Vietnamese patients with type 2 diabetes mellitus
    Nguyen, Thao H.
    Tran, Tam T. T.
    Nguyen, Nguyet K.
    Diep, Han G.
    Vo, Son D.
    Taxis, Katja
    Pham, Suol T.
    Nguyen, Thang
    [J]. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (05) : 449 - 456
12345